STOCK MARKET Strides Pharma shares over 3% after acquiring generic brands from Sandoz for US$ 12 million Mar 18, 2026
CORPORATES Strides Pharma receives Form 483 with four procedural observations following routine USFDA inspection at US facility Dec 24, 2025
Strides Pharma incorporates new subsidiary ‘Pivot Path’ to boost life sciences and digital innovation Apr 11, 2025
Strides Pharma Q3 FY25 Results: Revenue up 15% YoY to Rs 1,154 crore, Net Profit up 60% YoY Jan 30, 2025
Strides Pharma receives USFDA approval for acetaminophen and ibuprofen tablets, expanding OTC portfolio Jan 20, 2025